Wegovy weight loss pill now available in UK - here's what you need to know

Wegovy, a weight loss medication containing semaglutide, has become available in the United Kingdom. The drug works by mimicking a hormone released from the intestine after eating, which then acts on brain receptors to control appetite. This action leads to increased feelings of fullness, reduced hunger, and less craving for food.

“

The semaglutide in the jab and pill mimics the actions of a hormone called GPL-1 (glucagon-like-peptide-1), which is released from the intestine after people eat.

Common side effects associated with both the injectable and pill forms of Wegovy include gastrointestinal issues such as nausea, vomiting, constipation, and diarrhea. For the injectable form, localized skin reactions like redness, itching, or mild swelling at the injection site may occur. Some individuals may also experience headaches, tiredness, and stomach pain.

“

It acts on receptors in the brain that control appetite, making people feel fuller, less hungry and crave food less.

More serious, though rarer, complications can arise, including low blood sugar, pancreatitis, and severe allergic reactions. Patients are advised to consult the patient information leaflet for a comprehensive list of side effects and contraindications. The medication is not recommended for individuals under 18, pregnant or breastfeeding women. It is crucial for patients to discuss any pre-existing medical conditions or current medications with their doctor before starting treatment.

“

Very common side effects with both include stomach problems, like feeling sick, being sick (vomiting), constipation and diarrhoea.